ACTRN12621001524886进行中（未招募）未知
Queensland COVID-19 Vaccination (QoVAX) Safety and Efficacy Trial Program: Mixed Dose 1 and 2 Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 586
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •People in Queensland 18 years of age and older, who have received two doses of BNT162b2 or ChAdOx1 COVID vaccines, the second of which was received between 120-180 days prior to giving consent,
排除标准
- •1. Unable or decline to give informed consent
- •2. Have a contraindication to venepuncture
- •3. Insufficient literacy to read and understand the English or translated version of the participant information and consent forms who do not have a family member or interpreter to assist
- •4. Do not posses a smart phone or computer to access the participant information and complete the consent form and fill the questionnaire.
- •5. Are unable or unwilling to reach a pathology collection centre to donate samples.
研究者
相似试验
进行中（未招募）
不适用
Queensland COVID-19 Vaccination (QoVAX) Safety and Efficacy Trial Pilot Study in adults aged 18 years and over.COVID-19SARS-CoV2 virus immunityRespiratory - Other respiratory disorders / diseasesInflammatory and Immune System - Normal development and function of the immune systemInfection - Other infectious diseasesACTRN12621001543875Metro North Hospital and Health Service2,159
进行中（未招募）
1 期
COVERS (COVID-Vaccination Efficiency Risk and Safety Study)Coronavirus disease 2019 (COVID-19)EUCTR2021-000413-17-SERegion Skåne - Kliniska Studier Sverige, Forum Söder4,000
招募中
4 期
Optimising Q fever vaccination in Australia: Protecting our rural adolescentsQ FeverInfection - Other infectious diseasesInflammatory and Immune System - Normal development and function of the immune systemACTRN12622001185752niversity of Sydney1,100
已完成
3 期
Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type BHaemophilus Influenzae InfectionsHepatitis BTetanusDiphtheriaPertussisNCT01362517Crucell Holland BV131
招募中
不适用
Safety profile of COVID-19 vaccines and the comparison to COVID-19 symptomatologyZ20.8U07.1Contact with and exposure to other communicable diseasesCOVID-19, virus identifiedDRKS00024800Charité - Universitätsmedizin Berlin7,800